Colgate-Palmolive Q3 Sales Up, Net Income Flat Amid Pet Food Push

TL;DR

**Colgate's Q3 was a mixed bag: sales up slightly, but net income flat, making the $301M pet food acquisition and upcoming $200-300M restructuring program the real stories for future growth.**

AI Summary

Colgate-Palmolive Company reported a slight increase in net sales for the three months ended September 30, 2025, reaching $5,131 million, up from $5,033 million in the prior year, a 1.9% increase. However, net income attributable to Colgate-Palmolive Company decreased marginally to $735 million from $737 million in the same period. Diluted earnings per common share saw a modest rise to $0.91 from $0.90. For the nine months ended September 30, 2025, net sales were $15,152 million, a slight decrease from $15,156 million in 2024, while net income attributable to Colgate-Palmolive Company increased to $2,169 million from $2,150 million. A key business change was the acquisition of Care TopCo Pty Ltd (Prime100 pet food business) for approximately $301 million on April 30, 2025, expanding Hill's Pet Nutrition into the fresh pet food category in Australia. The company also approved a new three-year Strategic Growth and Productivity Program on July 31, 2025, estimated to incur pre-tax charges between $200 million and $300 million by December 31, 2028, primarily for employee-related costs (65% to 75%). Risks include the execution of this new productivity program and potential impacts from new accounting pronouncements, though most are not expected to have a material financial statement impact. The strategic outlook focuses on driving future growth and supporting the Company's 2030 strategy through organizational and supply chain optimization.

Why It Matters

Colgate-Palmolive's modest sales growth and stable net income demonstrate resilience in a competitive consumer goods market, but the slight dip in Q3 net income suggests margin pressures. The acquisition of Prime100 is a strategic move to capture growth in the premium pet food segment, directly challenging competitors like Nestlé's Purina and Mars Petcare. For investors, the new $200-$300 million Strategic Growth and Productivity Program signals a commitment to long-term efficiency, but also introduces near-term restructuring costs. Employees may face organizational changes and potential severance as 65% to 75% of the program's costs are employee-related. Customers could see new product offerings, particularly in pet nutrition, and potentially more streamlined supply chains.

Risk Assessment

Risk Level: medium — The company faces medium risk due to the newly approved Strategic Growth and Productivity Program, which is estimated to incur pre-tax charges of $200 million to $300 million by December 31, 2028. While aimed at efficiency, such large-scale restructuring initiatives carry execution risks and could impact short-term profitability and employee morale. Additionally, the acquisition of Prime100 for $301 million introduces integration risks and the challenge of successfully expanding into a new pet food category.

Analyst Insight

Investors should monitor the execution of the Strategic Growth and Productivity Program closely, particularly its impact on operating profit and cash flow over the next three years. Evaluate the integration of the Prime100 acquisition and its contribution to the Hill's Pet Nutrition segment's growth. Consider holding CL shares, as the strategic initiatives could drive long-term value, but be prepared for potential short-term volatility due to restructuring costs.

Financial Highlights

revenue

$15,152M

total Assets

$17,513M

net Income

$2,169M

eps

$2.67

cash Position

$1,279M

revenue Growth

-0.03%

Key Numbers

• $5.13B — Net Sales (Increased by 1.9% for the three months ended September 30, 2025, compared to $5.03B in 2024.)
• $735M — Net Income Attributable to Colgate-Palmolive Company (Slightly decreased from $737M in the prior year's quarter.)
• $0.91 — Diluted Earnings Per Common Share (Increased from $0.90 in the prior year's quarter.)
• $301M — Prime100 Acquisition Cost (Cash consideration paid on April 30, 2025, to enter the fresh pet food market in Australia.)
• $200M-$300M — Estimated Pre-Tax Restructuring Charges (Expected costs for the new Strategic Growth and Productivity Program by December 31, 2028.)
• 65%-75% — Employee-Related Restructuring Costs (Portion of the Strategic Growth and Productivity Program charges allocated to severance and termination benefits.)
• $1.279B — Cash and Cash Equivalents (Increased from $1.096B at December 31, 2024.)
• $1.113B — Debt Payable Within One-Year (Increased from $660M at December 31, 2024.)
• $2.745B — Net Cash Provided by Operations (Decreased from $2.838B for the nine months ended September 30, 2024.)
• $806.06M — Common Stock Shares Outstanding (As of September 30, 2025.)

Key Players & Entities

• COLGATE-PALMOLIVE COMPANY (company) — registrant
• Care TopCo Pty Ltd (company) — acquired company
• Prime100 (company) — pet food business acquired
• Hill's Pet Nutrition (company) — segment benefiting from acquisition
• FASB (regulator) — Financial Accounting Standards Board
• $5,131 million (dollar_amount) — net sales for three months ended September 30, 2025
• $735 million (dollar_amount) — net income attributable to Colgate-Palmolive Company for three months ended September 30, 2025
• $301 million (dollar_amount) — cash consideration for Prime100 acquisition
• $200 million (dollar_amount) — low end of estimated pre-tax charges for Strategic Growth and Productivity Program
• $300 million (dollar_amount) — high end of estimated pre-tax charges for Strategic Growth and Productivity Program

FAQ

Risk Factors

• Strategic Growth and Productivity Program Execution [medium — operational]: The company has approved a new three-year Strategic Growth and Productivity Program, estimated to incur pre-tax charges between $200 million and $300 million by December 31, 2028. A significant portion, 65% to 75%, is allocated to employee-related costs. Successful execution is critical for achieving organizational and supply chain optimization to support the 2030 strategy.
• New Accounting Pronouncements [low — regulatory]: The company notes potential impacts from new accounting pronouncements. While most are not expected to have a material financial statement impact, any unforeseen implications could affect financial reporting and investor understanding.

Industry Context

Colgate-Palmolive operates in the highly competitive global consumer staples market, specifically in oral care, personal care, home care, and pet nutrition. Key industry trends include a growing demand for premium and specialized products, particularly in pet food, and an increasing focus on sustainability and health-conscious offerings. Competition comes from large multinational corporations as well as smaller, agile brands.

Regulatory Implications

The company faces ongoing regulatory scrutiny related to product safety, advertising, and environmental standards across its global operations. New accounting pronouncements, while not currently expected to be material, represent a potential area of compliance risk that requires careful monitoring and implementation.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]

Key Dates

• 2025-04-30: Acquisition of Care TopCo Pty Ltd (Prime100 pet food business) — Expands Hill's Pet Nutrition into the fresh pet food category in Australia, representing a strategic move into a growing market segment.
• 2025-07-31: Approval of new three-year Strategic Growth and Productivity Program — Aims to optimize organizational and supply chain operations, with estimated pre-tax charges of $200M-$300M by end of 2028, signaling a focus on efficiency and future growth.
• 2025-09-30: End of third quarter and nine-month reporting period — Provides updated financial performance data, including net sales of $5,131M for the quarter and $15,152M for the nine months, and net income of $735M for the quarter and $2,169M for the nine months.

Glossary

Net income attributable to noncontrolling interests

Represents the portion of a subsidiary's net income that belongs to owners other than the parent company. (This line item is subtracted from total net income to arrive at the net income attributable to Colgate-Palmolive Company shareholders.)

Cumulative translation adjustments

Unrealized gains or losses arising from the translation of foreign currency financial statements of foreign subsidiaries into the reporting currency. (These adjustments impact Other Comprehensive Income and can significantly affect the total comprehensive income attributable to the company.)

Strategic Growth and Productivity Program

A company initiative designed to improve efficiency and drive future growth through organizational and supply chain optimization. (This program is a key strategic focus, with significant estimated costs and potential benefits for the company's long-term performance.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (The increase in Goodwill from $3,272M to $3,702M suggests recent acquisitions, likely including the Prime100 business.)

Year-Over-Year Comparison

For the three months ended September 30, 2025, Colgate-Palmolive reported a 1.9% increase in net sales to $5,131 million, compared to $5,033 million in the prior year. However, net income saw a marginal decrease to $735 million from $737 million. For the nine months, net sales were relatively flat ($15,152M vs $15,156M), while net income increased slightly to $2,169 million from $2,150 million. The company also saw an increase in cash and cash equivalents to $1,279 million from $1,096 million, but a significant rise in short-term debt to $1,113 million from $660 million.

Key Financial Figures

• $1.00 — ange on which registered Common Stock, $1.00 par value CL New York Stock Exchange

Filing Documents

• cl-20250930.htm (10-Q) — 1627KB
• exhibit10a-2025stockoption.htm (EX-10.A) — 87KB
• exhibit10b-2025rsuform2019.htm (EX-10.B) — 83KB
• exhibit31a_q32025.htm (EX-31.A) — 9KB
• exhibit31b_q32025.htm (EX-31.B) — 9KB
• exhibit32_093025xq32025.htm (EX-32) — 5KB
• image_0.jpg (GRAPHIC) — 24KB
• image_01.jpg (GRAPHIC) — 24KB
• 0000021665-25-000053.txt ( ) — 7845KB
• cl-20250930.xsd (EX-101.SCH) — 34KB
• cl-20250930_cal.xml (EX-101.CAL) — 67KB
• cl-20250930_def.xml (EX-101.DEF) — 207KB
• cl-20250930_lab.xml (EX-101.LAB) — 527KB
• cl-20250930_pre.xml (EX-101.PRE) — 379KB
• cl-20250930_htm.xml (XML) — 1285KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION COLGATE-PALMOLIVE COMPANY Condensed Consolidated Statements of Income (Dollars in Millions Except Per Share Amounts) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Net sales $ 5,131 $ 5,033 $ 15,152 $ 15,156 Cost of sales 2,082 1,959 6,047 5,977 Gross profit 3,049 3,074 9,105 9,179 Selling, general and administrative expenses 1,971 1,979 5,833 5,833 Other (income) expense, net 19 30 58 141 Operating profit 1,059 1,065 3,214 3,205 Non-service related postretirement costs 21 23 116 67 Interest expense 67 74 203 226 Interest income 21 18 56 51 Income before income taxes 992 986 2,951 2,963 Provision for income taxes 226 210 685 693 Net income including noncontrolling interests 766 776 2,266 2,270 Less: Net income attributable to noncontrolling interests 31 39 97 120 Net income attributable to Colgate-Palmolive Company $ 735 $ 737 $ 2,169 $ 2,150 Earnings per common share, basic $ 0.91 $ 0.90 $ 2.68 $ 2.62 Earnings per common share, diluted $ 0.91 $ 0.90 $ 2.67 $ 2.61 See Notes to Condensed Consolidated Financial Statements. 2 COLGATE-PALMOLIVE COMPANY Condensed Consolidated Statements of Comprehensive Income (Dollars in Millions) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Net income including noncontrolling interests $ 766 $ 776 $ 2,266 $ 2,270 Other comprehensive income (loss), net of tax: Cumulative translation adjustments 15 44 329 ( 168 ) Retirement plans and other retiree benefit adjustments 10 21 20 32 Gains (losses) on cash flow hedges 7 ( 7 ) ( 15 ) ( 5 ) Total Other comprehensive income (loss), net of tax 32 58 334 ( 141 ) Total Comprehensive income including noncontrolling interests 798 834 2,600 2,129 Less: Net income attributable to noncontrolling interests 31 39 97 120 Less: Cumulative translation adjustments attributable to noncontrolling interests ( 4 ) 3 — ( 5 ) Total Comp